Chronic Lyme Disease and Co-Infections: A Functional Medicine Approach to Persistent Symptoms
Chronic Lyme disease and tick-borne co-infections are among the most complex and misunderstood patterns in chronic illness care. For some patients, symptoms begin after a clear tick bite, rash, fever, joint pain, or flu-like illness. For others, the original exposure is missed, symptoms develop gradually, and the connection to Lyme disease, Babesia, Bartonella, or other tick-borne infections is not recognized until months or years later.
Early infection with Borrelia burgdorferi, the primary bacterium associated with Lyme disease, may respond to appropriate antibiotic treatment. But persistent Lyme symptoms are rarely that simple. Co-infections may require different therapeutic strategies, and months or years of repeated antibiotics do not necessarily resolve the deeper immune, inflammatory, neurological, mitochondrial, and toxic burden patterns that often keep patients symptomatic. (1,2)
Many patients continue to experience persistent fatigue, migrating pain, brain fog, neuropathy, sleep disruption, mood changes, dysautonomia, exercise intolerance, inflammatory flares, and poor recovery after treatment has been completed. These ongoing symptoms are commonly described as post-treatment Lyme disease syndrome, or PTLDS. Many patients and clinicians also use the term chronic Lyme disease to describe persistent, multi-system symptoms associated with Lyme disease, co-infections, immune dysregulation, and unresolved inflammatory burden. (1,2)
The challenge is that persistent Lyme symptoms are rarely explained by one mechanism alone.
In many complex cases, the problem is not simply “active infection” versus “no infection.” The clinical picture may involve overlapping layers of Borrelia exposure, tick-borne co-infections, immune dysregulation, neuroinflammation, mitochondrial dysfunction, biofilm-protected microbial forms, gut dysfunction, mold toxicity, heavy metal burden, mast cell activation, autonomic nervous system instability, and impaired detoxification capacity. (1,3)
This is why chronic Lyme recovery often requires a broader systems-based approach.
A functional medicine approach asks why the body remains stuck in patterns of inflammation, immune dysregulation, neurological irritation, poor cellular energy production, and reduced treatment tolerance. Instead of focusing only on whether one organism is present or absent, this model evaluates the terrain that allows persistent symptoms to continue: immune regulation, inflammatory load, mitochondrial function, detoxification capacity, gut health, nervous system stability, environmental exposures, and co-infection burden.
→ Functional & Integrative Medicine
What Is Lyme Disease and Why Can Symptoms Become Chronic?
Lyme disease is a tick-borne infection caused primarily by Borrelia burgdorferi in the United States. Borrelia is a spiral-shaped bacterium, or spirochete, transmitted through the bite of infected blacklegged ticks. Once transmitted, it may affect multiple systems of the body, including the skin, joints, nervous system, cardiovascular system, immune system, and connective tissue. (4)
Early Lyme disease may appear as a clear acute illness, but it does not always follow the classic textbook pattern. Some patients develop an expanding rash, fever, chills, headache, neck stiffness, swollen lymph nodes, muscle pain, or joint pain. Others never notice a tick bite, never develop a recognizable bull’s-eye rash, or experience symptoms that seem vague, intermittent, or unrelated at first. (4)
Common early Lyme disease symptoms may include:
Expanding rash, which may or may not have a bull’s-eye appearance
Fever or chills
Headache
Neck stiffness
Muscle and joint pain
Fatigue
Swollen lymph nodes
Flu-like symptoms after tick exposure
When Lyme disease is recognized early, appropriate antibiotic treatment may help clear acute Borrelia burgdorferi infection. The challenge is that many persistent cases are not driven by acute Borrelia infection alone. Symptoms may continue when diagnosis is delayed, treatment is incomplete, co-infections are present, immune dysregulation persists, or the body remains burdened by inflammation, toxins, gut dysfunction, mitochondrial stress, and nervous system instability. (1,2,3)
This distinction matters. Chronic Lyme symptoms are often multi-system symptoms, not just infectious symptoms.
Patients with persistent Lyme-related illness may experience:
Migrating joint or muscle pain
Chronic fatigue or post-exertional crashes
Brain fog, memory issues, or word-finding difficulty
Neuropathy, tingling, burning, or nerve pain
Headaches or pressure sensations
Sleep disruption
Anxiety, irritability, or mood changes
Dizziness, palpitations, or dysautonomia
Air hunger, night sweats, or temperature dysregulation
Food sensitivity, histamine symptoms, or mast cell reactivity
Poor recovery after stress, exercise, illness, or treatment
This is why a functional medicine approach does not look at Lyme disease only through the lens of one organism. It evaluates the broader pattern: infection history, co-infection risk, immune dysregulation, inflammatory load, mitochondrial function, detoxification capacity, gut health, environmental exposures, and nervous system resilience.
Lyme disease may begin with a tick bite, but persistent Lyme symptoms often continue because multiple systems remain dysregulated.
Acute Lyme Disease vs Chronic Lyme Disease vs PTLDS
The distinction between acute Lyme disease, post-treatment Lyme disease syndrome, and chronic Lyme disease is not just a matter of language. It also reflects differences in clinical training, diagnostic frameworks, testing limitations and interpretation, provider experience, and how seriously persistent symptoms are evaluated after tick exposure or treatment.
In conventional settings, Lyme disease is often approached through a narrow infectious disease model: identify acute Borrelia burgdorferi infection, treat with antibiotics, and consider the infection resolved if standard criteria are met. That model may be appropriate for straightforward early Lyme disease, but it often fails to explain patients with persistent fatigue, pain, brain fog, neuropathy, dysautonomia, inflammatory flares, co-infections, toxin burden, immune dysregulation, and poor recovery after treatment.
A Lyme-literate functional medicine approach asks a broader question: which systems remain dysregulated after infection, exposure, or treatment — and what is preventing the body from returning to normal immune, neurological, mitochondrial, and inflammatory regulation?
Acute Lyme Disease
Acute Lyme disease refers to early infection with Borrelia burgdorferi after a tick bite. This stage may involve recent tick exposure, an expanding rash, fever, chills, headache, neck stiffness, swollen lymph nodes, muscle aches, joint pain, and flu-like symptoms. Some patients develop the classic bull’s-eye rash, but many do not. (4)
When identified early, acute Borrelia burgdorferi infection is typically treated with antibiotics in conventional medical practice. In a functional medicine setting, early care may also include individualized support for immune regulation, inflammation, gut protection, detoxification capacity, mitochondrial function, and nervous system resilience.
Lyme disease can also be missed or minimized because symptoms are variable, tick bites are not always noticed, the classic rash is not always present, and early testing may be incomplete. Many patients with persistent Lyme-related symptoms are told their labs are normal, their symptoms are stress-related, or nothing is wrong, even while they continue to experience fatigue, pain, brain fog, neurological symptoms, dysautonomia, and poor recovery. This gap between test results and lived experience is one reason chronic Lyme and co-infection care requires a broader clinical lens from a Lyme-literate functional medicine provider.
However, early antibiotic treatment for Borrelia burgdorferi does not automatically address co-infections, delayed diagnosis, immune dysregulation, biofilm-protected forms, inflammatory burden, mitochondrial dysfunction, or the deeper terrain patterns that may contribute to persistent symptoms.
Post-Treatment Lyme Disease Syndrome
Post-treatment Lyme disease syndrome, or PTLDS, is a conventional medical term used to describe persistent symptoms following prior antibiotic treatment for Lyme disease. Symptoms vary widely, but may include chronic fatigue, musculoskeletal pain, brain fog, memory or concentration problems, sleep disruption, reduced stamina, post-exertional worsening, and impaired physical function. (1,2)
PTLDS confirms that symptoms remain after treatment, but it does not explain why recovery has plateaued. Research has proposed several possible contributors, including immune dysregulation, residual antigen exposure, tissue injury, altered inflammatory signaling, microbiome disruption, autonomic dysfunction, central sensitization, mitochondrial stress, and post-infectious changes in nervous system regulation. (2,3)
For some patients, persistent symptoms may also reflect unresolved infection, biofilm-protected or persister forms, untreated co-infections, or overlapping burdens such as gut dysfunction, mold exposure, toxin accumulation, mast cell activation, and impaired detoxification capacity. In many cases, there is not one isolated cause, but a combination of infectious, inflammatory, neurological, metabolic, and environmental factors affecting recovery.
For patients who have been told their Lyme disease was treated but continue to feel profoundly unwell, PTLDS can validate that their symptoms are real. It should not, however, end the clinical investigation. A Lyme-literate functional medicine approach looks beyond the diagnosis to identify which systems remain dysregulated, what is perpetuating symptoms, and where support is needed to restore recovery capacity.
Chronic Lyme Disease
Chronic Lyme disease is a broad clinical term commonly used to describe persistent, multi-system illness associated with Lyme disease, tick-borne co-infections, and poor recovery after tick exposure or prior treatment. Patients may continue to experience fatigue, pain, cognitive changes, sleep disruption, neurological symptoms, dysautonomia, exercise intolerance, inflammatory flares, and a reduced ability to function normally.
The term is not intended to suggest that every ongoing symptom is caused by active Borrelia infection alone. Rather, it recognizes that persistent Lyme-related illness can involve a complex interaction between infection history, co-infections, immune dysregulation, neuroinflammation, mitochondrial impairment, gut dysfunction, mast cell activation, environmental toxic burden, and impaired detoxification capacity.
For many patients, the defining experience is not simply that they had Lyme disease. It is that their body never fully returned to baseline.
The most important clinical question is not only whether an infection was present or treated. It is:
Why has the body not returned to normal regulation after infection, treatment, or tick exposure?
That question changes the treatment strategy. A root-cause functional medicine approach looks beyond repeated antimicrobial pressure alone and evaluates the systems that influence recovery: immune regulation, inflammatory burden, neurological stability, mitochondrial energy production, gut health, toxin clearance, co-infection patterns, and the body’s overall capacity to tolerate treatment and repair.
Why Lyme Symptoms Can Persist After Antibiotics
Persistent symptoms after prior antibiotic treatment for Lyme disease can have more than one driver. In some cases, unresolved infection or unrecognized co-infections may remain part of the picture. In others, the original infection may have triggered lasting immune dysregulation, inflammatory signaling, neurological disruption, mitochondrial stress, or tissue-level injury. Antibiotic exposure may also disrupt the gut microbiome, impair intestinal barrier function, and contribute to further immune dysregulation in some people. (5) Many patients have overlapping infectious, metabolic, neurological, gastrointestinal, toxic, and environmental contributors that continue to affect recovery. (1,2)
This is why chronic Lyme disease and persistent Lyme-related illness are rarely resolved through one intervention alone. Recovery depends on identifying which systems remain dysregulated, what is perpetuating symptoms, and whether the body has sufficient physiologic capacity to tolerate treatment, regulate inflammation, and repair.
Persistent Immune Dysregulation
The immune system does more than respond to infection. It communicates continuously with the nervous system, endocrine system, gut barrier, vascular system, connective tissue, and mitochondria. After Lyme disease or other tick-borne infections, that signaling does not always return to baseline.
Persistent immune dysregulation may involve altered cytokine signaling, oxidative stress, inflammatory mediator release, immune-cell dysfunction, and tissue-level inflammation. These mechanisms may contribute to fatigue, migrating pain, sleep disruption, brain fog, flu-like flares, sensory sensitivity, and reduced exercise tolerance. (2,3)
Patients may notice that symptoms worsen after stress, poor sleep, physical exertion, hormonal changes, illness, certain foods, alcohol, chemical exposure, or a new supplement. This is not simply “being sensitive.” It may reflect a body that remains physiologically reactive because inflammatory and immune-regulatory systems have not stabilized.
Common patterns may include:
Migrating muscle or joint pain
Brain fog or slowed cognitive processing
Poor sleep or waking unrefreshed
Histamine intolerance, flushing, or food reactivity
Chemical sensitivity
Increased symptoms after stress or exertion
Relapsing inflammatory flares
Difficulty tolerating antimicrobials, detoxification protocols, or supplements
When immune dysregulation is pronounced, more antimicrobial pressure is not always the appropriate starting point. The body may first require support for inflammatory regulation, elimination pathways, mitochondrial function, gut integrity, mast cell stability, and nervous system resilience.
Neuroinflammation and Nervous System Dysfunction
Many people with chronic Lyme disease or tick-borne co-infections develop symptoms that point to nervous system involvement, not simply fatigue or joint pain. Brain fog, memory changes, word-finding difficulty, headaches, light or sound sensitivity, neuropathy, internal vibration, anxiety, insomnia, dizziness, palpitations, and autonomic instability can make daily life feel increasingly unpredictable.
These symptoms may be associated with neuroinflammation, altered immune signaling, microglial activation, vascular inflammation, mitochondrial stress, and dysfunction affecting the brain, spinal cord, and peripheral nerves. (2,3)
When the nervous system remains inflamed or dysregulated, the brain may have more difficulty processing sensory input, maintaining energy production, regulating pain, adapting to stress, and restoring normal sleep-wake rhythms. This can leave patients feeling overstimulated yet exhausted—“wired but tired”—with reduced resilience after physical activity, cognitive effort, emotional stress, poor sleep, or even ordinary daily demands.
For many patients, this pattern is particularly distressing because the symptoms are invisible but deeply disruptive. A Lyme-literate functional medicine approach evaluates neurological symptoms within the broader picture of immune dysregulation, co-infections, mitochondrial dysfunction, mast cell activation, toxin exposure, sleep disruption, and autonomic nervous system imbalance.
Mitochondrial Dysfunction and Reduced Energy Production
Fatigue in chronic Lyme disease is not ordinary tiredness.
Mitochondria are responsible for producing cellular energy in the form of ATP. The brain, muscles, heart, immune system, and nervous system all depend heavily on mitochondrial function. Chronic inflammation, oxidative stress, infections, toxins, poor sleep, nutrient deficiencies, and immune activation can all impair mitochondrial efficiency.
When mitochondrial function declines, patients may experience:
Severe fatigue
Post-exertional crashes
Muscle weakness
Brain fog
Poor exercise tolerance
Slow recovery after stress
Lightheadedness
Increased pain sensitivity
Reduced cognitive stamina
This is one reason chronic Lyme treatment must address energy production, not just microbial burden. If the body cannot generate enough energy to detoxify, repair tissue, regulate inflammation, and maintain nervous system stability, treatment tolerance often declines.
Immune Evasion and Persistent Tick-Borne Illness
Borrelia burgdorferi and several tick-borne co-infections have developed mechanisms that can help them avoid, alter, or outlast normal immune surveillance. In Lyme disease, Borrelia can change surface proteins through antigenic variation, making it more difficult for the adaptive immune system to recognize the organism consistently over time. It can also interfere with elements of the complement system, an important part of the body’s early immune defense. (6)
This does not mean the immune system is inactive. In many chronic Lyme presentations, the immune system may remain highly reactive while still failing to fully clear the underlying trigger. That combination can contribute to ongoing inflammation, fluctuating symptoms, tissue irritation, and a pattern in which patients feel unwell despite inconclusive or inconsistent laboratory findings.
Co-infections can add another layer of complexity. Babesia infects red blood cells and may add another layer of diagnostic complexity when organisms are not circulating in sufficient quantity at the time of testing. (7) Bartonella infection can also involve variable, multi-system symptom patterns that require careful interpretation within the broader clinical history.
For this reason, Lyme and co-infection evaluation cannot rely on one antibody result, one blood draw, or one symptom pattern alone. Clinical history, exposure risk, symptom progression, co-infection patterns, direct and indirect testing, immune status, inflammatory burden, and treatment response all matter.
Biofilms, Persister Forms, and Persistent Lyme Symptoms
Borrelia burgdorferi is not a static organism. Laboratory studies show that it can alter its growth state, form aggregated biofilm-like communities, and develop antibiotic-tolerant persister populations under certain conditions. These findings are relevant because slower-growing or protected forms may be less responsive to antimicrobial pressure in laboratory models and may help explain why persistent Lyme symptoms remain an active area of research. (8)
Biofilms are structured microbial communities surrounded by a protective extracellular matrix. This matrix can reduce access to immune surveillance and antimicrobial agents. Persister cells are different: they are not genetically antibiotic-resistant organisms, but metabolically altered cells that enter a lower-activity state and may survive exposure that eliminates more actively growing bacteria.
For patients, the important point is not that every persistent symptom proves active infection. It does not. Persistent Lyme symptoms can reflect several overlapping processes, including microbial persistence, residual antigen exposure, immune dysregulation, inflammatory tissue injury, untreated co-infections, nervous system dysfunction, mitochondrial impairment, and environmental or toxic burden.
That complexity is why chronic Lyme care requires more than a one-dimensional “infection present or absent” model. A Lyme-literate evaluation considers the full clinical pattern: symptom progression, prior treatment history, co-infection risk, testing limitations, inflammatory burden, immune resilience, gut and microbiome health, toxic exposures, and treatment tolerance.
Lyme Disease Co-Infections: Why Borrelia May Not Be the Whole Story
A single tick bite can transmit more than one tick-borne pathogen. Lyme disease may occur alongside other tick-borne infections, and these co-infections can change the symptom pattern, severity, testing picture, treatment tolerance, and pace of recovery. Commonly evaluated co-infections include Babesia, Bartonella, Ehrlichia, Anaplasma, and Rickettsia species. (7)
This matters because Borrelia burgdorferi does not affect every tissue or immune pathway in the same way as other tick-borne infections. A patient whose symptoms are driven primarily by air hunger and drenching sweats may present very differently from someone whose dominant pattern is neuropathy, vascular pain, fever, low blood counts, or liver inflammation.
Babesia: Air Hunger, Sweats, and Red Blood Cell Stress
Babesia is a parasite that infects red blood cells. Some people have no symptoms, while others develop a flu-like illness or a more persistent pattern involving fatigue, chills, sweats, headache, body aches, and weakness. Because Babesia affects red blood cells, it may also contribute to hemolytic anemia and reduced oxygen delivery in more severe cases. (7)
Symptoms that may raise suspicion for Babesia include:
Air hunger or an inability to take a satisfying breath
Night sweats, sometimes drenching or cyclical
Chills, temperature swings, or feverish episodes
Severe fatigue that is disproportionate to activity
Head pressure or headaches
Dizziness or lightheadedness
Exercise intolerance
Shortness of breath
Anxiety-like surges or autonomic symptoms
Babesia can be especially serious in older adults, immunocompromised individuals, and people without a functioning spleen. (7)
Bartonella: Neurological, Vascular, and Pain-Related Symptoms
Bartonella infection can involve vascular, neurological, immune, and connective-tissue symptoms. Its symptom pattern can overlap with Lyme disease, but prominent neurological symptoms, burning pain, vascular discomfort, sleep disruption, and neuropsychiatric changes may warrant further clinical consideration.
Symptoms sometimes associated with Bartonella-like presentations include:
Burning, tingling, or shooting nerve pain
Foot pain, shin pain, or migrating musculoskeletal pain
Neuropathy or heightened sensory sensitivity
Anxiety, agitation, irritability, or sleep disruption
Cognitive changes or worsening brain fog
Light sensitivity
Vascular pain or tenderness
Tender nodules or skin changes
Bartonella symptoms can be highly variable. The clinical pattern, exposure history, testing, immune status, and response to prior treatment all matter when determining whether further evaluation is appropriate.
Ehrlichia and Anaplasma: Acute Flu-Like Illness and Abnormal Blood Markers
Ehrlichia and Anaplasma are intracellular bacterial infections that often cause an acute flu-like illness. Symptoms can include fever, chills, headache, muscle aches, fatigue, nausea, and malaise. Laboratory findings may include low white blood cell counts, low platelets, and elevated liver enzymes. (7)
These infections can become severe, particularly when diagnosis or treatment is delayed. Acute fever, severe headache, confusion, marked weakness, rash, or abnormal blood counts after tick exposure should be evaluated promptly.
Rickettsia and Rocky Mountain Spotted Fever: Symptoms That Require Urgent Evaluation
Rickettsial infections, including Rocky Mountain spotted fever, can become serious quickly. Symptoms may include fever, severe headache, muscle pain, nausea, rash, and systemic illness. A rash may be absent early or may not follow a classic pattern, so its absence should not be used to rule out concern. (7)
Suspected Rocky Mountain spotted fever or another acute rickettsial illness requires urgent conventional medical evaluation. Delayed treatment can lead to severe complications.
Persistent symptoms after tick exposure should not automatically be reduced to Lyme disease alone. A thorough Lyme-literate evaluation considers the full tick-borne illness picture, including symptom clusters, geography, tick exposure history, timing of illness, prior treatment, immune status, testing limitations, inflammatory markers, and the patient’s overall recovery pattern.
Why Conventional Lyme Disease Testing Can Be Incomplete
Standard Lyme disease testing may provide an incomplete picture when interpreted without symptom history, exposure risk, timing of illness, co-infection evaluation, and broader clinical context.
Most conventional Lyme testing relies on a two-tier antibody-based process. Rather than directly detecting Borrelia, this approach measures whether the immune system has produced a measurable antibody response. That distinction matters because antibody production can be delayed, suppressed, altered by prior treatment, or absent despite a clinically concerning history. Early in infection, testing may be negative before antibodies have developed. Later, antibodies may remain detectable for months or years after prior exposure, which means a positive result does not automatically confirm active infection or explain current symptoms. (9)
Several factors can complicate Lyme disease testing and interpretation:
Testing before antibodies have developed
No recalled tick bite or recognizable rash
Symptoms that do not follow a classic Lyme presentation
Immune suppression, immune dysregulation, or poor antibody production
Prior antibiotic treatment, which may affect antibody development or test interpretation
Positive antibodies from prior exposure rather than current illness
Co-infections that require separate testing methods
Persistent symptoms driven by immune dysregulation, neuroinflammation, mitochondrial dysfunction, gut disruption, mast cell activation, toxic burden, or nervous system dysfunction
A negative standard Lyme test should not automatically end the clinical investigation when the patient’s symptom pattern, exposure history, timing of illness, or co-infection risk remains concerning. Testing is one part of the diagnostic picture and should be interpreted alongside geography, symptom progression, physical findings, prior treatment, immune status, inflammatory burden, and recovery pattern.
Comprehensive Lyme and Co-Infection Testing Beyond Standard Antibody Tests
Because standard antibody testing does not directly detect pathogens and may provide an incomplete picture of tick-borne illness, a Lyme-literate evaluation should not rely on antibody testing alone when active infection, co-infections, or persistent symptoms remain clinically relevant.
Advanced testing may include a multi-method strategy that combines:
Indirect antibody assessment in serum, including targeted Bartonella IgG IFA testing
Direct detection of pathogen DNA in blood through digital PCR
Serial blood collection over three days to improve the opportunity to detect low-abundance or intermittently circulating organisms
Direct urine antigen detection for Borrelia using Nanotrap® technology
Targeted testing for Borrelia, Babesia, Bartonella, and other clinically relevant tick-borne pathogens
Nanotrap® urine antigen testing uses particles designed to capture and concentrate Borrelia OspA antigen directly from urine. Unlike antibody testing, it does not depend on the patient mounting a measurable immune response. This may provide useful additional information when Lyme disease is suspected but the standard serology is negative, inconclusive, or difficult to interpret after prior treatment. (10)
Digital PCR looks for pathogen DNA directly in blood. A three-day collection strategy may improve the opportunity to identify organisms present at very low levels or circulating intermittently, particularly in complex cases involving suspected Borrelia, Babesia, or Bartonella infection. (11)
Bartonella IFA serology adds a different layer of information by assessing immune exposure to clinically relevant Bartonella species, including B. henselae, B. quintana, B. vinsonii berkhoffii, and B. koehlerae. Antibody results do not independently confirm active infection, but they can add meaningful context when interpreted alongside direct-detection testing, symptoms, exposure history, and treatment history. (12)
No single Lyme or co-infection test is definitive in every case. Direct-detection methods may miss organisms that are not circulating in sufficient quantity in the sample, while antibody testing may be negative early, suppressed, absent, or difficult to interpret after prior infection or treatment. A layered testing strategy can provide a more complete clinical picture, but laboratory findings must always be interpreted within the patient’s history and symptom pattern.
The purpose of comprehensive Lyme and co-infection testing is not simply to generate a positive or negative result. It is to clarify which factors may be contributing to persistent symptoms, including active microbial burden, untreated co-infections, post-infectious immune dysregulation, neuroinflammation, autonomic dysfunction, mitochondrial impairment, microbiome disruption, or overlapping contributors.
Testing should support clinical reasoning—not replace it.
The Functional Medicine View of Chronic Lyme Disease
A functional medicine approach to chronic Lyme disease asks a broader question than whether Borrelia or a tick-borne co-infection is present: why has the body remained inflamed, reactive, exhausted, and unable to fully recover?
Persistent Lyme-related illness is rarely driven by one mechanism alone. Active infection or co-infections may be part of the clinical picture, but many patients also have overlapping immune dysregulation, neuroinflammation, mitochondrial dysfunction, gut disruption, mast cell activation, toxic burden, impaired detoxification and elimination, autonomic nervous system dysfunction, and reduced physiologic resilience.
Rather than treating symptoms in isolation or increasing antimicrobial intensity without considering the patient’s overall capacity, a root-cause functional medicine approach evaluates the systems that influence recovery, treatment tolerance, and long-term stability.
Key priorities may include:
Identifying active tick-borne infections and co-infections when clinically indicated
Reducing inflammatory burden while supporting immune regulation
Improving mitochondrial energy production, cellular repair, and post-exertional recovery
Restoring gut barrier integrity and microbiome health
Supporting detoxification and elimination pathways
Evaluating mold exposure, heavy metals, and environmental toxicants
Addressing mast cell activation, histamine intolerance, and chemical sensitivity
Stabilizing autonomic dysfunction, sleep disruption, and neurological reactivity
Correcting nutrient deficiencies that affect immune function, energy production, and tissue repair
Supporting blood sugar stability, circadian rhythm, stress physiology, and restorative movement
Improving treatment tolerance before increasing antimicrobial intensity
This sequencing matters. Patients with chronic Lyme disease may worsen when treatment is more aggressive than their current physiologic capacity can tolerate. A significant Herxheimer reaction is not automatically evidence that a protocol is working; it may indicate that inflammatory burden, microbial die-off, toxin mobilization, impaired elimination, or nervous system stress has exceeded the body’s ability to regulate the response.
The goal is not simply to apply more antimicrobial pressure. It is to determine which factors are most actively perpetuating illness—ongoing microbial burden, untreated co-infections, immune and nervous system dysregulation, toxic exposure, mitochondrial depletion, gut dysfunction, or a combination of these factors—and then sequence care in a way that supports meaningful recovery rather than repeated destabilization.
→ Detoxification & Environmental Medicine
Mold, Heavy Metals, Gut Dysfunction, and MCAS in Chronic Lyme
Chronic Lyme disease and tick-borne co-infections rarely exist in isolation. Many patients have overlapping inflammatory drivers that can intensify symptoms, impair immune regulation, and make treatment harder to tolerate.
Mold exposure, mycotoxins, heavy metals, environmental toxicants, gut dysbiosis, intestinal permeability, mast cell activation, histamine intolerance, viral reactivation, hormone disruption, and chronic stress physiology may all contribute to the persistent, reactive pattern seen in complex Lyme cases.
Mold Toxicity and Chronic Lyme Disease
Mycotoxins are toxic compounds produced by certain indoor molds. In susceptible individuals, mold exposure may increase inflammatory burden, impair immune regulation, aggravate neuroinflammation, and place additional demand on detoxification and elimination pathways. (13)
Patients with overlapping mold illness and chronic Lyme may experience worsening fatigue, brain fog, headaches, sinus symptoms, chemical sensitivity, sleep disruption, histamine symptoms, neurological reactivity, and mast cell activation. When mold exposure remains active or toxic burden is high, aggressive antimicrobial Lyme treatment may be poorly tolerated until inflammatory regulation, drainage, and detoxification capacity improve.
Heavy Metals and Environmental Toxicants
Mercury, lead, arsenic, pesticides, solvents, plastics, and other environmental toxicants can increase oxidative stress and interfere with mitochondrial function, immune regulation, endocrine signaling, neurological stability, and detoxification capacity.
These exposures do not necessarily cause Lyme disease, but they may lower the body’s resilience and make recovery more difficult. In patients with chronic Lyme symptoms, toxic burden may contribute to fatigue, cognitive dysfunction, sensory sensitivity, headaches, immune reactivity, and reduced tolerance to treatment.
Gut Dysfunction and the Microbiome
The gut is central to immune regulation, inflammation control, nutrient absorption, bile flow, detoxification, and microbial balance. Prior antibiotic exposure, dysbiosis, intestinal permeability, constipation, poor bile flow, low stomach acid, food sensitivities, and disrupted microbiome diversity can perpetuate systemic inflammation and make Lyme recovery more difficult.
A compromised gut may contribute to:
Histamine intolerance and food reactivity
Nutrient deficiencies
Impaired detoxification and elimination
Immune dysregulation
Brain fog and fatigue
Skin symptoms
Joint pain
Inflammatory flares
For many patients, gut repair is not separate from Lyme care. It is part of restoring immune tolerance, improving nutrient status, reducing inflammatory triggers, and increasing the body’s ability to tolerate treatment.
Mast Cell Activation and Histamine Intolerance
Mast cells are immune cells that release histamine and other inflammatory mediators in response to infection, toxins, allergens, stress, hormones, and environmental exposures. In complex inflammatory conditions, mast-cell mediator release may contribute to symptoms such as flushing, itching, hives, palpitations, gastrointestinal distress, and chemical or food reactivity. (14)
Symptoms can vary substantially between individuals and may worsen with infections, allergens, medications, stress, hormonal shifts, or environmental exposures.
When mast cell activation syndrome, or MCAS, is part of the clinical picture, treatment often needs to be paced carefully. Antimicrobials, binders, sauna, supplements, foods, stress, hormonal shifts, and detoxification protocols can all trigger symptom flares when the immune and nervous systems are unstable.
This is why treatment sequencing matters. Before increasing antimicrobial intensity, it may be necessary to reduce exposure, stabilize mast cell activity, improve bowel regularity and elimination, support sleep and nervous system regulation, and lower the overall inflammatory burden.
Herxheimer Reactions: When Treatment Triggers Flares
A Jarisch–Herxheimer reaction, often shortened to a Herxheimer reaction or “Herx,” is an acute inflammatory response that can occur after antimicrobial treatment begins for certain infections, including Lyme disease. It is generally associated with a sudden worsening of symptoms shortly after treatment is started or intensified, often within hours to the first day. Symptoms may include fever or chills, headache, body aches, increased joint or muscle pain, fatigue, brain fog, nausea, sleep disruption, mood changes, or flu-like discomfort. (15)
In chronic Lyme care, patients often use “die-off” to describe any treatment flare. That language can be useful, but it is important not to assume that every worsening of symptoms is a true Herxheimer reaction or evidence that a protocol is working.
In complex Lyme and co-infection cases, treatment flares may also intensify when inflammatory byproducts, microbial debris, bile-bound compounds, or mobilized toxins accumulate faster than the body can process and eliminate them. Constipation, poor bile flow, inadequate hydration, impaired liver or lymphatic function, gut dysfunction, and limited detoxification capacity can all reduce treatment tolerance and increase inflammatory burden.
A flare during treatment may reflect:
An inflammatory response associated with microbial die-off
Increased cytokine activity
Mobilization of inflammatory byproducts or toxins beyond the body’s current detoxification and elimination capacity
Mast cell activation or histamine release
Gut disruption, constipation, poor bile flow, or impaired elimination
Medication, herbal, or supplement intolerance
Excessively rapid dosing or multiple treatment changes at once
Blood sugar instability, sleep loss, or nervous system overload
An unrelated illness, allergic reaction, or adverse effect that requires reassessment
Supporting detoxification pathways does not mean forcing aggressive “detox” protocols. In chronic Lyme care, it means ensuring the body can process and eliminate inflammatory byproducts through regular bowel movements, adequate hydration, bile flow, liver function, lymphatic circulation, sleep, and nervous system regulation before antimicrobial intensity is increased. When these foundations are impaired, treatment may need to be slowed, simplified, or sequenced differently.
This distinction matters. A true Herxheimer reaction is typically acute and time-limited; persistent or escalating symptoms should not automatically be normalized as “die-off.” New severe symptoms, high fever, rash, shortness of breath, chest pain, fainting, marked palpitations, or signs of an allergic reaction warrant prompt medical evaluation.
Functional medicine care emphasizes treatment tolerance and sequencing. If a patient cannot sleep, maintain bowel regularity, regulate blood sugar, manage histamine reactivity, clear inflammatory byproducts, or maintain nervous system stability, aggressive antimicrobial treatment may create more physiologic stress than benefit.
The goal is not to push through every flare. It is to pace treatment in a way that reduces unnecessary inflammatory overload while supporting immune regulation, detoxification and elimination capacity, gut function, mitochondrial resilience, and neurological recovery.
Herbal Treatment for Chronic Lyme Disease: When the Buhner Protocol May Fit
Herbal protocols, including the Buhner Protocol, may be considered in chronic Lyme disease and co-infection care when a patient requires a more individualized, systems-based approach than antimicrobial treatment alone. Many botanicals used in Lyme-focused protocols have antimicrobial, anti-inflammatory, immune-modulating, endothelial-supportive, and tissue-protective properties. Commonly discussed herbs include Japanese Knotweed, Cat’s Claw, Chinese Skullcap, Andrographis, Cryptolepis, Artemisia, and Houttuynia. (16)
The role of botanical medicine is not simply to “kill” organisms. In complex Lyme cases, herbs may be selected to address overlapping concerns such as inflammatory signaling, immune dysregulation, neuroinflammation, vascular irritation, oxidative stress, tissue protection, and treatment tolerance while also applying targeted antimicrobial pressure.
Herbal medicine is not automatically gentle. Botanicals are pharmacologically active and may interact with medications, influence blood pressure, blood sugar, clotting, liver metabolism, immune activity, pregnancy status, and detoxification capacity. Some patients also react strongly to antimicrobial herbs, especially when mast cell activation, histamine intolerance, gut dysfunction, constipation, poor bile flow, mold-related illness, or nervous system sensitization are present.
For this reason, herbal protocols should be individualized according to symptom pattern, suspected co-infections, medication use, sensitivity level, inflammatory burden, detoxification and elimination capacity, and current phase of recovery. A patient with significant neurological reactivity, severe fatigue, MCAS symptoms, or poor treatment tolerance may need stabilization and foundational support before introducing more intensive botanical antimicrobials.
Within a functional medicine framework, herbal protocols are not used as a stand-alone strategy. They are sequenced within a broader plan that may include immune regulation, detoxification and elimination support, mitochondrial nutrients, gut repair, mast cell stabilization, sleep restoration, nervous system regulation, and environmental medicine.
Functional Medicine Treatment Priorities for Persistent Lyme Symptoms
Chronic Lyme disease and co-infection care must be sequenced carefully.
The order matters because many patients begin treatment already inflamed, depleted, reactive, constipated, toxic, histamine-sensitive, or neurologically sensitized. Introducing antimicrobial herbs too aggressively before the body has enough regulatory and elimination capacity can intensify symptoms, destabilize the nervous system, and reduce treatment tolerance.
Priority 1: Stabilize the Foundation
Before increasing antimicrobial intensity, the goal is to improve the patient’s ability to regulate inflammation, recover from stress, and tolerate treatment.
This may include:
Sleep and circadian rhythm support
Blood sugar stability
Hydration and electrolytes
Constipation correction and bowel regularity
Gentle lymphatic support
Nervous system regulation
Reduction of major inflammatory triggers
Basic nutrient repletion
Histamine and mast cell stabilization when needed
For many patients, this phase is not a delay in treatment. It is what makes later treatment possible.
Priority 2: Support Detoxification and Elimination Capacity
Detoxification support may include attention to liver function, bile flow, bowel regularity, hydration, kidney function, lymphatic circulation, sweating capacity, and gut-mediated elimination.
The goal is not to force aggressive detoxification. It is to ensure that inflammatory byproducts, microbial debris, mobilized toxins, and bile-bound compounds can be processed and eliminated without overwhelming the patient. When elimination pathways are impaired, treatment may need to be slowed, simplified, or sequenced differently.
Priority 3: Restore Mitochondrial Function and Energy Production
Mitochondrial support is often necessary when fatigue, post-exertional worsening, brain fog, muscle weakness, and poor recovery are prominent.
Support may include targeted nutrients, antioxidants, minerals, amino acids, redox support, restorative movement, light exposure, pacing, and reduction of inflammatory burden. Improving cellular energy production can help patients tolerate treatment, recover from flares, and gradually rebuild physical and cognitive capacity.
Priority 4: Address Gut Health and Immune Regulation
Gut dysfunction can perpetuate inflammation, histamine intolerance, nutrient deficiencies, immune dysregulation, and poor treatment tolerance.
This phase may include microbiome support, intestinal barrier repair, food sensitivity reduction, bile flow support, constipation management, nutrient repletion, and immune-modulating strategies. Improving gut health is not separate from Lyme treatment; it is part of restoring immune tolerance and reducing chronic inflammatory burden.
Priority 5: Address Lyme Disease and Co-Infections Strategically
Once the patient has enough stability and treatment tolerance, individualized herbal protocols may be used to address Borrelia and suspected co-infections.
Treatment selection depends on symptom pattern, exposure history, testing, suspected microbial burden, inflammatory load, medication use, mast cell activity, detoxification capacity, and clinical response. Babesia, Bartonella, Ehrlichia, Anaplasma, and Rickettsia may require different therapeutic strategies than Borrelia alone.
The goal is not maximal antimicrobial intensity. It is targeted, tolerable treatment that reduces microbial burden without creating repeated inflammatory overload.
Priority 6: Repair, Rebuild, and Reduce Relapse Risk
As symptoms improve, the focus shifts from intensive treatment toward long-term resilience.
This may include connective tissue and endothelial support, hormone balance, nervous system flexibility, immune tolerance, exercise rehabilitation, mitochondrial recovery, restorative movement, sleep optimization, toxin reduction, and relapse prevention.
Recovery is not simply the absence of acute symptoms. It is the return of energy, cognitive clarity, physical capacity, emotional resilience, and the ability to tolerate normal life without repeated crashes.
→ Chronic Illness & Complex Cases
Why Chronic Lyme Care Must Be Individualized
No two chronic Lyme disease cases look the same. The symptom pattern, co-infection burden, inflammatory load, environmental exposures, treatment history, and physiologic resilience can vary substantially from one patient to the next.
One person may be dominated by Babesia-like symptoms such as air hunger, night sweats, dizziness, and autonomic instability. Another may present with Bartonella-like patterns involving neuropathy, anxiety, vascular pain, insomnia, and neurological sensitivity. Another may be highly reactive due to mold exposure, MCAS, histamine intolerance, constipation, and severe supplement sensitivity. Others may have profound fatigue, post-exertional worsening, cognitive dysfunction, and reduced exercise tolerance driven by mitochondrial stress and post-infectious nervous system dysregulation.
This is why protocol-only care often falls short. A plan that is appropriate for one patient may be too aggressive, poorly timed, or incomplete for another.
Treatment decisions should account for:
Symptom pattern and severity
Tick exposure history and geography
Prior treatment history
Co-infection suspicion and testing findings
Mold exposure, toxic burden, and environmental triggers
Gut function, bowel regularity, and microbiome disruption
Detoxification and elimination capacity
Immune status and inflammatory burden
Medication use, interactions, and pregnancy status
Mast cell activity and histamine reactivity
Mitochondrial resilience and post-exertional worsening
Nervous system sensitivity, sleep quality, and autonomic function
Patient goals, pace, and treatment tolerance
Chronic Lyme recovery is not about doing everything at once or applying the same protocol to every patient. It is about identifying the dominant drivers of illness, addressing the most limiting factors first, and sequencing care in a way the body can tolerate. The objective is not simply symptom suppression, but gradual restoration of immune regulation, energy production, neurological stability, detoxification capacity, and long-term resilience.
Functional Medicine Care for Chronic Lyme Disease in Denver
At Denver Sports & Holistic Medicine, chronic Lyme disease, tick-borne co-infections, and persistent post-treatment symptoms are approached through a root-cause, systems-based model of care. The focus is not limited to infection history alone. Evaluation considers the overlapping factors that may be preventing recovery, including immune dysregulation, co-infection patterns, neuroinflammation, mitochondrial dysfunction, gut imbalance, mold exposure, environmental toxic burden, mast cell activation, autonomic dysfunction, and impaired detoxification and elimination capacity.
The goal is not to force the body through aggressive treatment before it is ready. It is to build enough physiologic stability, resilience, and treatment tolerance that deeper interventions can be introduced without repeatedly overwhelming the immune system, nervous system, gut, or detoxification pathways.
An individualized functional medicine plan may include a detailed clinical history, targeted laboratory evaluation, inflammatory and immune assessment, Lyme and co-infection testing when indicated, gut and environmental toxin evaluation, nutrient repletion, botanical medicine, detoxification and elimination support, acupuncture, nervous system regulation, mitochondrial support, and carefully sequenced care.
When persistent Lyme symptoms, suspected co-infections, mold-related illness, fatigue, brain fog, pain, sleep disruption, autonomic symptoms, or complex chronic illness patterns are affecting daily life, a root-cause evaluation can help clarify which systems need support and where care should begin.
You may request a complimentary 15-minute consultation with Dr. Martina Sturm to discuss your health concerns and determine whether this approach is appropriate for your next step.
Key Insights About Chronic Lyme Disease and Co-Infections
Persistent Lyme symptoms are not always explained by one organism or one test result.
Lyme disease and co-infections may involve overlapping immune dysregulation, neuroinflammation, mitochondrial dysfunction, gut disruption, mast cell activation, toxic burden, and autonomic dysfunction.
Standard antibody testing can be incomplete and should be interpreted alongside symptom history, exposure risk, co-infection patterns, timing, and broader clinical context.
A Herxheimer reaction or treatment flare is not always a sign that a protocol is working; worsening symptoms may indicate inflammatory overload, impaired elimination, mast cell activation, intolerance, or treatment intensity that exceeds current capacity.
Herbal Lyme protocols may be useful when carefully individualized, but they should be sequenced within a broader plan that supports detoxification and elimination, gut health, mitochondrial function, nervous system regulation, and immune resilience.
Chronic Lyme recovery is not about doing everything at once. It depends on identifying the dominant drivers of illness and sequencing care in a way the body can tolerate.
Frequently Asked Questions About Chronic Lyme Disease and Co-Infections
What is chronic Lyme disease?
Chronic Lyme disease is a broad clinical term often used to describe persistent, multi-system symptoms that continue after tick exposure, Lyme disease, prior treatment, or suspected co-infections. Symptoms may involve fatigue, pain, brain fog, neuropathy, sleep disruption, dysautonomia, exercise intolerance, inflammation, and reduced recovery capacity.
What is the difference between chronic Lyme disease and PTLDS?
Post-treatment Lyme disease syndrome, or PTLDS, is a conventional medical term for persistent symptoms following prior antibiotic treatment for Lyme disease. Chronic Lyme disease is broader and may include unresolved co-infections, immune dysregulation, neuroinflammation, mitochondrial dysfunction, gut disruption, mold exposure, mast cell activation, toxic burden, or other factors that may be contributing to ongoing illness.
Can Lyme symptoms persist after antibiotics?
Yes. Some people continue to experience fatigue, pain, cognitive changes, sleep disruption, neurological symptoms, or reduced physical function after prior antibiotic treatment. Persistent symptoms may reflect immune dysregulation, residual inflammatory signaling, tissue injury, co-infections, nervous system dysfunction, mitochondrial stress, gut disruption, or overlapping contributors rather than one single cause.
Can Lyme disease testing be negative even if symptoms are concerning?
Yes. Standard Lyme testing is largely antibody-based and may be difficult to interpret depending on timing, immune response, prior treatment, and co-infection risk. A negative test does not automatically explain persistent symptoms or exclude the need for a broader clinical evaluation when exposure history and symptom patterns remain concerning.
What are common Lyme co-infections?
Common tick-borne co-infections include Babesia, Bartonella, Ehrlichia, Anaplasma, and Rickettsia species. Each can produce different symptom patterns and may require separate testing and individualized treatment strategies.
Can chronic Lyme disease cause brain fog, anxiety, or neurological symptoms?
Chronic Lyme-related illness may involve brain fog, headaches, neuropathy, dizziness, insomnia, sensory sensitivity, anxiety, palpitations, and autonomic dysfunction. These symptoms may be associated with neuroinflammation, immune dysregulation, mitochondrial stress, autonomic nervous system dysfunction, co-infections, mast cell activation, or inflammatory signaling affecting the brain and peripheral nerves.
What is a Herxheimer reaction in Lyme treatment?
A Herxheimer reaction is an acute inflammatory flare that may occur after antimicrobial treatment begins or intensifies. Symptoms may include chills, headache, body aches, fatigue, brain fog, increased pain, nausea, or flu-like discomfort. Not every treatment flare is a true Herxheimer reaction; worsening symptoms may also reflect histamine activation, poor elimination, gut disruption, supplement intolerance, excessive dosing, or nervous system overload.
Can mold toxicity or MCAS worsen chronic Lyme symptoms?
Yes. Mold exposure, mycotoxins, mast cell activation, histamine intolerance, gut dysfunction, heavy metals, and environmental toxicants may amplify inflammation, neurological symptoms, chemical sensitivity, fatigue, sleep disruption, and treatment intolerance in some patients with chronic Lyme disease.
Can herbal protocols help chronic Lyme disease?
Herbal protocols may be considered as part of individualized chronic Lyme and co-infection care. Botanicals such as Japanese Knotweed, Cat’s Claw, Chinese Skullcap, Andrographis, Cryptolepis, Artemisia, and Houttuynia are commonly used in Lyme-focused herbal approaches. Because herbal medicines are pharmacologically active, treatment should be individualized based on symptoms, co-infections, medication use, mast cell activity, gut function, detoxification capacity, and overall tolerance.
Why does chronic Lyme treatment need to be individualized?
No two chronic Lyme cases are the same. Treatment priorities depend on symptom severity, tick exposure history, co-infection risk, prior treatment, mold and toxic burden, gut health, immune status, mitochondrial resilience, nervous system sensitivity, medication interactions, pregnancy status, and the body’s ability to tolerate treatment.
Still Have Questions?
If the topics above reflect ongoing symptoms or unanswered concerns, a brief conversation can help clarify whether a root-cause approach is appropriate.
Resources
Frontiers in Medicine - Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
Infectious Disease Clinics of North America - Persistent Symptoms After Treatment of Lyme Disease
Frontiers in Medicine - Persistent Symptoms After Treatment for Lyme Disease: “Confusion Worse Confounded”
Centers for Disease Control and Prevention - Signs and Symptoms of Untreated Lyme Disease
Microorganisms - Antibiotics as Major Disruptors of Gut Microbiota
Pathogens - The Brilliance of Borrelia: Mechanisms of Host Immune Evasion by Lyme Disease-Causing Spirochetes
Centers for Disease Control and Prevention - Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers
Antimicrobial Agents and Chemotherapy - Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Centers for Disease Control and Prevention - Clinical Testing and Diagnosis for Lyme Disease
Galaxy Diagnostics - Lyme Borrelia Nanotrap® Urine Antigen Testing
Galaxy Diagnostics - Triple Draw BBB Direct Detect: Digital PCR Testing for Borrelia, Babesia, and Bartonella
Galaxy Diagnostics - Bartonella IgG Detect: Four-Species IFA Serology
Food and Chemical Toxicology - An Update on Immunotoxicity and Mechanisms of Action of Six Environmental Mycotoxins
Journal of Allergy and Clinical Immunology - Mast Cell Activation Syndrome: Current Understanding and Research Needs
StatPearls - Jarisch-Herxheimer Reaction
Integrative Medicine - A Comprehensive Review of Herbal Supplements Used for Persistent Symptoms Attributed to Lyme Disease